Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement
View/ Open
Author
Woo, P.
Wilkinson, N.
Prieur, A-M.
Southwood, T.
Leone, V.
Livermore, P.
Wythe, H.
Thomson, D.
Kishimoto, T.
Attention
2299/1372